| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Departments of Emergency Medicine, Surgery, Henry Ford Health Systems, Detroit
2 From the Department of Internal Medicine, Southern Illinois University, Springfield, Ill.
3 From the Department of Emergency Medicine, Henry Ford Health Systems, Detroit
4 From the Department of Biostatistics, Henry Ford Health Systems, Detroit
Background: Studies evaluating the dose of epinephrine required to optimize return of spontaneous circulation and survival after CPR have shown that doses greater than recommended by advanced cardiac life support (ACLS) improve coronary perfusion pressure and short-term resuscitation rates. Since survival has not improved, it is possible that higher doses of epinephrine may be physiologically detrimental in the postresuscitation period.
Objective: The object of this study is to measure the effect of the total cumulative dose of epinephrine given during ACLS on the hemodynamic, oxygen transport, and utilization variables in the postresuscitation period.
Design: A prospective nonrandomized control trial of inception cohorts.
Setting: A large urban emergency department and intensive care unit.
Patients: Forty-nine successfully resuscitated witnessed, normothermic, nontraumatic, out-of-hospital patients, who had suffered cardiac arrests.
Interventions: All patients were treated according to ACLS guidelines; however, the epinephrine dose (0.01 to 0.2 mg/kg or 1 to 14 mg) was selected at the clinician's discretion and given through central venous access every 3 to 5 min. Hemodynamic, oxygen transport, and utilization variables were measured on a return of spontaneous circulation, and at least every 30 min thereafter under a standardized postresuscitation protocol.
Main outcome measures: Hemodynamic, oxygen transport/utilization variables, and mortality in patients resuscitated from cardiac arrest. The total cumulative dose of epinephrine given during ACLS until a return of spontaneous circulation was recorded.
Results: A total cumulative epinephrine dose of 15 mg was found to best predict 24-h mortality. Of the 49 patients, 20 received less than 15 mg (group 1) and 29 received greater than 15 mg (group 2). Age, premorbid health status, sex, presenting rhythm, and duration of cardiac arrest were similar in both groups. The 24-h survival was 17 of 20 (85%) and 12 of 29 (41%) in group 1 and 2, respectively (p<0.002). Over the first 6 h of the postresuscitation period, both groups had similar mean arterial pressure (MAP), mixed venous oxygen saturation, and systemic oxygen extraction ratio (all p>0.1). Group 2, however, had a significantly lower cardiac index (CI), systemic oxygen consumption (VO2), and systemic oxygen delivery (Do2) (all p<0.01). Systemic vascular resistance index (SVRI), initial and 6-h lactic acid levels were significantly higher in group 2 (all p<0.03).
Conclusions: The administration of all doses of epinephrine during the resuscitation of out-of-hospital cardiac arrest is associated with impairment of Do2 and VO2 in the postresuscitation period. Both duration and severity of these impairments correlate with the total cumulative epinephrine dose given during the resuscitation. Thus, inadvertent catecholamine toxicity represents a further complicating factor in the production of postresuscitation disease. Diagnostic and therapeutic interventions addressed toward mitigating these potentially reversible adverse effects may impact morbidity and mortality in out-of-hospital cardiac arrests.
Key Words: ACLS • cardiac arrest • cardiomyopathy • catecholamine • CPR • epinephrine • epinephrine toxicity • high-dose epinephrine • oxygen consumption • oxygen delivery • oxygen extraction • oxygen utilization • postresuscitation
Submitted on January 31, 1994
Accepted on May 4, 1994
This article has been cited by other articles:
|
|
 |
|
  The International Liaison Committee on Resuscitati The International Liaison Committee on Resuscitation (ILCOR) Consensus on Science With Treatment Recommendations for Pediatric and Neonatal Patients: Pediatric Basic and Advanced Life Support Pediatrics, May 1, 2006; 117(5): e955 - e977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Part 12: Pediatric Advanced Life Support Circulation, December 13, 2005; 112(24_suppl): IV-167 - IV-187. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Laurent, M. Monchi, J.-D. Chiche, L.-M. Joly, C. Spaulding, B.e. Bourgeois, A. Cariou, A. Rozenberg, P. Carli, S. Weber, et al. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2110 - 2116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Hilwig, R. A. Berg, K. B. Kern, and G. A. Ewy Endothelin-1 Vasoconstriction During Swine Cardiopulmonary Resuscitation Improves Coronary Perfusion Pressures but Worsens Postresuscitation Outcome Circulation, May 2, 2000; 101(17): 2097 - 2102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Wenzel, K. H. Lindner, A. C. Krismer, E. A. Miller, W. G. Voelckel, and W. Lingnau Repeated Administration of Vasopressin but Not Epinephrine Maintains Coronary Perfusion Pressure After Early and Late Administration During Prolonged Cardiopulmonary Resuscitation in Pigs Circulation, March 16, 1999; 99(10): 1379 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Carpenter and K. R. Stenmark High-dose Epinephrine Is Not Superior to Standard-dose Epinephrine in Pediatric In-hospital Cardiopulmonary Arrest Pediatrics, March 1, 1997; 99(3): 403 - 408. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
